Banque Cantonale Vaudoise’s Antares Pharma, Inc. ATRS Stock Holding History

Banque Cantonale Vaudoise’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,000	Closed	-$41K	–	1396
2022 Q1	$41K	Hold	10,000	–	–	﹤0.01%	1075
2021 Q4	$36K	Hold	10,000	–	–	﹤0.01%	1116
2021 Q3	$36K	Hold	10,000	–	–	﹤0.01%	1100
2021 Q2	$44K	Hold	10,000	–	–	﹤0.01%	1059
2021 Q1	$41K	Hold	10,000	–	–	﹤0.01%	1014
2020 Q4	$40K	Buy	+10,000	New	+$32.4K	﹤0.01%	966

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Banque Cantonale Vaudoise's ATRS Position: Q2 2022 in Review

Banque Cantonale Vaudoise sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 10,000 shares — an estimated $41K sold.

Banque Cantonale Vaudoise first reported a position in ATRS in Q4 2020 and held it in 6 quarters. The position peaked at $44K in Q2 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Banque Cantonale Vaudoise reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Banque Cantonale Vaudoise sold 10,000 Antares Pharma, Inc. shares in Q2 2022, an estimated $41K.
Banque Cantonale Vaudoise first reported a position in Antares Pharma, Inc. in Q4 2020 and held it in 6 quarters.
Banque Cantonale Vaudoise's Antares Pharma, Inc. position peaked at $44K in Q2 2021.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2022, filed 2 Aug 2022.